4 Overstated
Exposure to electromagnetic frequencies increases the body's depletion of magnesium.
"there's a good indication that the more that you're exposed to those type of environments, the increased depletion of key minerals such as magnesium comes into effect." (said at 0:03:26)
There is no clinical or epidemiological evidence in humans demonstrating that environmental electromagnetic frequency (EMF) exposure depletes whole-body magnesium levels. Preliminary experimental research is limited to animal data; a single rat study found that long-term exposure to high-intensity extremely low-frequency magnetic fields (500 μT for 2 hours daily over 10 months) resulted in reduced magnesium concentrations in rib bone tissue, whereas lower exposure (100 μT) showed no significant difference compared to sham controls. These preliminary animal findings under high-dose laboratory conditions do not support the broad claim that common environmental EMF exposure depletes magnesium in humans.
An intravenous magnesium push, especially combined with vitamin B6, can abate migraine headaches.
"I have abated migraines like that with a magnesium push. So that's an IV for the listeners. It's an IV that you actually administer not terribly quickly, but it's not a drip. It's in a big syringe and you can abate that with some B6. You can really abate a migraine." (said at 0:34:40)
The host's claim that an intravenous magnesium push, particularly when combined with vitamin B6, can abate acute migraine headaches overstates the evidence. Systematic reviews and meta-analyses of randomized controlled trials (RCTs) evaluating IV magnesium sulfate for acute migraine yield mixed and generally weak support. A meta-analysis of double-blind RCTs found no significant overall reduction in acute pain relief or need for rescue analgesia compared to controls. Another systematic review noted conflicting evidence across trials, with limited benefit observed primarily in specific subgroups (such as migraine with aura) or at delayed time points (>60 minutes). Furthermore, combining IV magnesium with vitamin B6 (pyridoxine) rests on uncontrolled clinical reports and narrative accounts of nutrient protocols like the "Myers' cocktail," rather than high-quality clinical trial data.
- context: Intravenous nutrient therapy: the "Myers' cocktail". (Alternative medicine review : a journal of clinical therapeutic 2002) · cited 30x in the literature
"The modified "Myers' cocktail," which consists of magnesium, calcium, B vitamins, and vitamin C, has been found to be effective against acute asthma attacks, migraines, fatigue (including chronic fatigue syndrome), fibromyalgia, acute muscle spasm, upper respiratory tract infections, chronic sinusitis, seasonal allergic rhinitis, cardiovascular disease, and other disorders." (abstract, background, passage verified)
pubmed - contradicts: The use of intravenous magnesium sulphate for acute migraine: meta-analysis of randomized … (European journal of emergency medicine : official journal of the European Society for Emergency Medicine 2014) · cited 43x in the literature
"The meta-analyses have failed to demonstrate a beneficial effect of intravenous magnesium in terms of reduction in pain relief in acute migraine in adults, showed no benefit in terms of the need for rescue medication and in fact have shown that patients treated with magnesium were significantly more likely to report side-effects/adverse events." (abstract, conclusions, passage verified)
pubmedfull study (doi) - partial: Intravenous Magnesium Sulfate to Treat Acute Headaches in the Emergency Department: A Syst… (Headache 2019) · cited 32x in the literature
"While we cannot draw a firm conclusion on the efficacy or benefit of intravenous magnesium sulfate in the treatment of acute non-traumatic headaches, the existing evidence indicates potential benefits in pain control beyond 1 hour, aura duration, and need for rescue analgesia." (abstract, conclusions, passage verified)
pubmedfull study (doi)
A standard dose of Prozac (fluoxetine) causes as much damage to bone integrity as extended use of prednisone.
"I found a study back when I was in naturopathic college still showing that just the regular dose of Prozac was um as bad on bone integrity as being on prednisone for an extended period of time." (said at 0:44:34)
While selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine (Prozac) are associated with modest reductions in bone mineral density and an increased relative risk of fractures (pooled relative risk of ~1.5 to 1.7 in meta-analyses of observational studies), equating a standard dose of fluoxetine to extended systemic prednisone therapy substantially overstates the magnitude of this effect. Long-term glucocorticoid therapy is one of the most potent causes of secondary osteoporosis and rapid bone loss, whereas the absolute bone loss and fracture risk associated with SSRIs are considerably smaller and confounded by depression-related lifestyle factors and fall risk. Furthermore, no clinical trials or comparative cohort studies show equivalent bone degradation between standard-dose SSRIs and chronic prednisone exposure.
- context: Use of selective serotonin reuptake inhibitors and risk of fracture: a systematic review a… (Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2012) · cited 123x in the literature
"A meta-analysis of these 12 observational studies showed that the overall risk of fracture was higher among people using SSRIs (adjusted odds ratio [OR] = 1.69, 95% confidence interval [CI] 1.51-1.90, I(2 ) = 89.9%)." (abstract, results)
pubmedfull study (doi) - context: SSRIs: bad to the bone? (Innovations in clinical neuroscience 2012) · cited 33x in the literature
"Despite an overall favorable side-effect profile, our examination of 19 studies, one review, and one meta-analysis indicates that these unique antidepressants appear to have negative effects on bone, particularly with regard to bone mineral density and fracture risk." (abstract, results, passage verified)
pubmed - context: Alliance between selective serotonin reuptake inhibitors and fracture risk: an updated sys… (European journal of clinical pharmacology 2020) · cited 35x in the literature
"Our results showed that SSRIs were significantly associated with an increased fracture risk (relative risk of 1.62, 95% CI 1.52-1.73; P < 0.000; I 2 = 90.8%)." (abstract, results)
pubmedfull study (doi)
Therapeutic doses of glycine contribute significantly to promoting deep sleep.
"you got a a a therapeutic dose of glycine is one of the big factors that really contributes to deep sleep." (said at 0:54:20)
Preliminary clinical trials (typically using 3 g at bedtime) and animal studies show that oral glycine can lower core body temperature, reduce non-REM sleep latency, and improve subjective sleep quality and daytime fatigue. However, claiming that glycine is a major or primary factor driving deep sleep overstates the available evidence. Clinical studies remain small and limited, with reviews noting that larger randomized controlled trials are needed to confirm the magnitude and clinical significance of its effects on sleep architecture.
Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.